NCT Number: NCT06211569
Our study aims to assess the prevalence of adenomyosis and endometriosis in patients consulting for elective fertility preservation through the diagnosis of these pathologies by transvaginal pelvic ultrasound. Imaging data will be compared with clinical data (patient characteristics, clinical symptoms) as well as the assessment of anxiety, depression, and quality of life collected from the women.
Interested in participating?
Request Info29 year–37 year
Female
Observational
Paris, Île-de-France Region, 75014, France
Location status: Recruiting
Mathilde BOURDON
PRINCIPAL_INVESTIGATOR
Mathilde BOURDON, MD
CONTACT
Pietro SANTULLI
SUB_INVESTIGATOR
Adenomyosis and endometriosis are two heterogeneous benign gynecological pathologies, in terms of the presence of diverse phenotypes and their symptomatic presentation: While some women are entirely asymptomatic, others experience pelvic pain, infertility, or abnormal uterine bleeding.
Assessing the prevalence of these two pathologies is challenging: On the one hand, a significant number of women are asymptomatic and not considered in the calculation; on the other hand, endometriosis and adenomyosis are often underdiagnosed, leading to delayed diagnosis.
Endometriosis and adenomyosis are frequently associated. Improving knowledge about the epidemiology of endometriosis and adenomyosis is crucial as both are major causes of clinical symptoms that adversely affect the quality of life in numerous women. This is a significant issue for women's health due to the associated suffering, numerous surgical interventions, healthcare expenses, and the suggested link with pathologies that may affect other organs. Understanding the disease could lead to improved treatment and the development of preventive strategies.
Therefore, it is urgent to determine the frequency of endometriosis and adenomyosis, as well as the correlation between women's characteristics, especially their clinical symptoms, and different phenotypes. In order to assess the prevalence of adenomyosis and endometriosis in a population of women of reproductive age, the investigators intend to conduct this single-center study focusing on patients consulting for non-medical fertility preservation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Usual follow-up
Time frame: Up to month 6
Search for endometriosis and adenomyosis on transvaginal pelvic ultrasound and characterisation of lesions.
Time frame: Inclusion
Socio-demographic data
Time frame: Inclusion
Medical history
Time frame: Inclusion
Between 26 (Poor quality of life) and 130 (good quality of life)
Time frame: Inclusion
2 scores between 0 (No anxiety or depression) and 21 (lots of anxiety and depression)
Contact information is provided by the study sponsor or research team.
Marie Benhammani-Godard
CONTACT
Mathilde BOURDON, MD
CONTACT
Assistance Publique - Hôpitaux de Paris
Other
Study of the Prevalence of Endometriosis and Adenomyosis in Women of Childbearing Age Consulting for Non-medical Oocyte Self-preservation
Acronym: PrevADEOSE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07138469
Elective Fertility Preservation
Clermont-Ferrand, Auvergne, France
View Trial DetailsNCT07728695
Adenomyosis, Adnexal Diseases
Belmont, Massachusetts, United States
View Trial DetailsNCT07713108
Adenomyosis, Chronic Pelvic Pain
Pécs, Baranya, Hungary
View Trial DetailsNCT07205614
Adenomyosis, Dysmenorrhea
Kristiansand, Agder, Norway
View Trial Details